» Articles » PMID: 36307883

RNA Binding Proteins in MLL-rearranged Leukemia

Overview
Publisher Biomed Central
Specialty Hematology
Date 2022 Oct 29
PMID 36307883
Authors
Affiliations
Soon will be listed here.
Abstract

RNA binding proteins (RBPs) have recently emerged as important post-transcriptional gene expression regulators in both normal development and disease. RBPs influence the fate of mRNAs through multiple mechanisms of action such as RNA modifications, alternative splicing, and miR-mediated regulation. This complex and, often, combinatorial regulation by RBPs critically impacts the expression of oncogenic transcripts and, thus, the activation of pathways that drive oncogenesis. Here, we focus on the major features of RBPs, their mechanisms of action, and discuss the current progress in investigating the function of important RBPs in MLL-rearranged leukemia.

Citing Articles

Three-dimensional chromatin landscapes in MLLr AML.

Sui P, Wang Z, Zhang P, Pan F Exp Hematol Oncol. 2024; 13(1):56.

PMID: 38778427 PMC: 11110396. DOI: 10.1186/s40164-024-00523-5.


Inflammation as a driver of hematological malignancies.

Saluja S, Bansal I, Bhardwaj R, Beg M, Palanichamy J Front Oncol. 2024; 14:1347402.

PMID: 38571491 PMC: 10987768. DOI: 10.3389/fonc.2024.1347402.


Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins.

Chen T, Huang H, Zhu S, Chen X, Pu K, Wang D Exp Hematol Oncol. 2024; 13(1):18.

PMID: 38374003 PMC: 10877858. DOI: 10.1186/s40164-024-00488-5.


Alternative splicing and related RNA binding proteins in human health and disease.

Tao Y, Zhang Q, Wang H, Yang X, Mu H Signal Transduct Target Ther. 2024; 9(1):26.

PMID: 38302461 PMC: 10835012. DOI: 10.1038/s41392-024-01734-2.


METTL1 mediated tRNA mG modification promotes leukaemogenesis of AML via tRNA regulated translational control.

Zhao P, Xia L, Chen D, Xu W, Guo H, Xu Y Exp Hematol Oncol. 2024; 13(1):8.

PMID: 38268051 PMC: 10807064. DOI: 10.1186/s40164-024-00477-8.

References
1.
Du W, Yang W, Liu E, Yang Z, Dhaliwal P, Yang B . Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016; 44(6):2846-58. PMC: 4824104. DOI: 10.1093/nar/gkw027. View

2.
Liu W, Cai H, Lin M, Zhu L, Gao L, Zhong R . MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1. Exp Cell Res. 2016; 343(2):248-257. DOI: 10.1016/j.yexcr.2016.03.026. View

3.
Gebauer F, Schwarzl T, Valcarcel J, Hentze M . RNA-binding proteins in human genetic disease. Nat Rev Genet. 2020; 22(3):185-198. DOI: 10.1038/s41576-020-00302-y. View

4.
Minuesa G, Albanese S, Xie W, Kazansky Y, Worroll D, Chow A . Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. Nat Commun. 2019; 10(1):2691. PMC: 6584500. DOI: 10.1038/s41467-019-10523-3. View

5.
Moorman A, Ensor H, Richards S, Chilton L, Schwab C, Kinsey S . Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010; 11(5):429-38. DOI: 10.1016/S1470-2045(10)70066-8. View